BDF Gestion Cuts Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

BDF Gestion lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,669 shares of the company’s stock after selling 2,685 shares during the period. BDF Gestion’s holdings in GE HealthCare Technologies were worth $1,616,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Mesirow Financial Investment Management Inc. increased its position in shares of GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock valued at $383,000 after purchasing an additional 1,159 shares during the last quarter. Cathy Pareto & Associates Inc. purchased a new stake in GE HealthCare Technologies during the fourth quarter worth about $670,000. LMR Partners LLP bought a new stake in GE HealthCare Technologies in the third quarter worth about $7,387,000. Principal Financial Group Inc. grew its position in shares of GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after acquiring an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $1,396,000. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Stock Up 1.9 %

Shares of GEHC opened at $89.55 on Friday. The firm has a market cap of $40.91 billion, a P/E ratio of 24.60, a P/E/G ratio of 2.88 and a beta of 1.11. GE HealthCare Technologies Inc. has a 1 year low of $72.52 and a 1 year high of $94.55. The stock has a 50 day simple moving average of $82.76 and a two-hundred day simple moving average of $84.95. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.99 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.